Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Other Non-Current Liabilities (2018 - 2025)

Dna X filings provide 8 years of Other Non-Current Liabilities readings, the most recent being $171000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities fell 89.94% to $171000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $171000.0, a 89.94% decrease, with the full-year FY2025 number at $171000.0, down 89.94% from a year prior.
  • Other Non-Current Liabilities hit $171000.0 in Q4 2025 for Dna X, down from $1.8 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.8 million in Q3 2025 to a low of $171000.0 in Q4 2025.
  • Median Other Non-Current Liabilities over the past 5 years was $1.5 million (2023), compared with a mean of $1.4 million.
  • The widest YoY moves for Other Non-Current Liabilities: up 16.12% in 2025, down 89.94% in 2025.
  • Dna X's Other Non-Current Liabilities stood at $1.4 million in 2021, then increased by 1.42% to $1.4 million in 2022, then rose by 6.93% to $1.5 million in 2023, then increased by 11.19% to $1.7 million in 2024, then crashed by 89.94% to $171000.0 in 2025.
  • The last three reported values for Other Non-Current Liabilities were $171000.0 (Q4 2025), $1.8 million (Q3 2025), and $1.8 million (Q2 2025) per Business Quant data.